All Medik8 products undergo many forms of testing before they arrive ready to purchase on the market. This includes in-house stability and sensory testing to ensure the high quality of our formulations, consumer and clinical studies to test the overall effectiveness of our products, and analytical trials to validate newly discovered, innovative product technologies.
For example, we conducted a unique analytical stability trial on our revolutionary Crystal Retinal™ formulation to test the efficacy of our patent-pending stabilisation complex. The complex was designed to ensure the retinal is stabilised throughout its whole life cycle - from raw material, all the way onto our skin. A unique analytical method was developed by scientists at Medik8 and the School of Life and Medical Sciences Division at the University of Hertfordshire to study the behaviour of retinal over time. Analytical technique UV-Vis was used to assess the stability of our final Crystal Retinal formulation, with the results displaying how much of a substance is actually present in a formula. We compared the UV-Vis spectrum of stabilised, encapsulated Crystal Retinal, alongside a control of unstabilised, unencapsulated Crystal Retinal. We found that almost all of the stabilised, crystal-encapsulated retinal remained after one year, while the unstabilised retinal degraded within just one month.